Siga Technologies (SIGA) Net Income towards Common Stockholders (2010 - 2025)

Siga Technologies (SIGA) posted Net Income towards Common Stockholders of -$6.4 million for Q3 2025, down 117.94% on a QoQ basis from $35.5 million in Q2 2025, and down 573.67% year-over-year from $1.3 million in Q3 2024.

Siga Technologies (SIGA) Net Income towards Common Stockholders (2010 - 2025) Analysis & Trends

Siga Technologies' Net Income towards Common Stockholders history runs 16 years deep, the most recent figure standing at -$6.4 million for Q3 2025.

  • Quarterly Net Income towards Common Stockholders fell 573.67% year-over-year to -$6.4 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $28.7 million (down 51.65% YoY) and the FY2024 annual result came in at $59.2 million, down 13.01% from the prior year.
  • Net Income towards Common Stockholders was -$6.4 million for Q3 2025 at Siga Technologies, down from $35.5 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $73.4 million in Q4 2021 and bottomed at -$6.4 million in Q3 2025.
  • A 5-year average of $13.6 million and a median of -$258928.0 in 2021 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders surged 9000.73% — and 2025, when it plunged 573.67%.
  • Siga Technologies' Net Income towards Common Stockholders stood at $73.4 million in 2021, then sank by 101.11% to -$811794.0 in 2022, then jumped by 9000.73% to $72.3 million in 2023, then tumbled by 36.45% to $45.9 million in 2024, then plunged by 113.86% to -$6.4 million in 2025.
  • Business Quant data shows SIGA's Net Income towards Common Stockholders at -$6.4 million in Q3 2025, $35.5 million in Q2 2025, and -$408223.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 370.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -2.35 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 274.90 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 57.00 Mn
10 Siga Technologies 223.05 Mn 68.08 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -6.37 Mn
Jun 30, 2025 35.48 Mn
Mar 31, 2025 -408,223.00
Dec 31, 2024 45.92 Mn
Sep 30, 2024 1.34 Mn
Jun 30, 2024 1.80 Mn
Mar 31, 2024 10.32 Mn
Dec 31, 2023 72.26 Mn
Sep 30, 2023 -393,066.00
Jun 30, 2023 -2.88 Mn
Mar 31, 2023 -917,677.00
Dec 31, 2022 -811,794.00
Sep 30, 2022 33.04 Mn
Jun 30, 2022 1.99 Mn
Mar 31, 2022 -364,455.00
Dec 31, 2021 73.38 Mn
Sep 30, 2021 -3.11 Mn
Jun 30, 2021 -258,928.00
Mar 31, 2021 -1.73 Mn
Dec 31, 2020 20.16 Mn